This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Holland & Knight Health Dose: February 3, 2026

The federal government has been in a partial shutdown since late last week, with several federal agencies – including the U.S. Department of Health and Human Services...

United States Healthcare

HK

Holland & Knight

HHS GPS V2.0 + HRSA "Strategic Priority Areas": Impact On Federal Grant Recipients Engaged In Pediatric Gender-affirming Care

Effective October 1, 2025, the US Department of Health and Human Services (HHS) implemented grants policy statement (GPS) v2.0, consistent with its prior adoption...

United States Healthcare

SR

McDermott Will & Schulte

CMS Doubles Down On RADV Audit Changes

On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024.

United States Healthcare

CM

Crowell & Moring LLP

Hospitals: Prepare Now For Mandatory Provider-Based Attestation Process

All hospitals that are paid under the Medicare Outpatient Prospective Payment System and operate off-campus outpatient departments should prepare for submission of mandatory provider-based attestations (PBAs), even if they have submitted them in the past.

United States Healthcare

SR

McDermott Will & Schulte

Congress Probes Chinese Biotech GLP-1 Product Compliance

United States Healthcare

KM

Katten Muchin Rosenman LLP

Of Drugs And DTC Platforms: American Consumerism, TrumpRx, Telehealth, And The Specter Of Congressional Intervention

United States Healthcare

SM

Sheppard

The 9th Circuit's EKRA Ruling: Implications For Behavioral Health And Clinical Labs

United States Healthcare

DW

Dickinson Wright PLLC

Joint Commission Announces Key Accreditation Updates For 2026

United States Healthcare

SR

McDermott Will & Schulte

Mississippi Obstetrics System Of Care: What Hospital Leaders Need To Know

United States Healthcare

BS

Butler Snow LLP

NSCEB Paper Outlines Policy Options To Modernize Oversight Of Biotechnology Products

United States Healthcare

BC

Bergeson & Campbell

Addressing Addiction Through The Great American Recovery Initiative (Trump EO Tracker)

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

FDA Clinical Decision Support Software Guidance Refresh : Clearer Rules, Broader Innovation

United States Healthcare

KM

Katten Muchin Rosenman LLP

FDA's Draft Guidance For Cosmetics Industry Explains Records-Access Authority During Inspections

United States Healthcare

WR

Wiley Rein

District Court Certifies 23(b)(3) Class Action Alleging Injury From Misrepresentations That Pet Food Was "Healthy" Despite Presence Of PFAS

United States Healthcare

MG

Manko, Gold, Katcher & Fox

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Holland & Knight Health Dose: February 3, 2026

The federal government has been in a partial shutdown since late last week, with several federal agencies – including the U.S. Department of Health and Human Services...

United States Healthcare

HK

Holland & Knight

Hospitals: Prepare Now For Mandatory Provider-Based Attestation Process

All hospitals that are paid under the Medicare Outpatient Prospective Payment System and operate off-campus outpatient departments should prepare for submission of mandatory provider-based attestations (PBAs), even if they have submitted them in the past.

United States Healthcare

SR

McDermott Will & Schulte

Congress Probes Chinese Biotech GLP-1 Product Compliance

Although the FDA recently implemented additional safeguards related to imported GLP-1 products, the safety of GLP-1 active pharmaceutical ingredient ("API") remains a key congressional focus.

United States Healthcare

KM

Katten Muchin Rosenman LLP

Of Drugs And DTC Platforms: American Consumerism, TrumpRx, Telehealth, And The Specter Of Congressional Intervention

United States Healthcare

SM

Sheppard

NSCEB Paper Outlines Policy Options To Modernize Oversight Of Biotechnology Products

United States Healthcare

BC

Bergeson & Campbell

FDA Clinical Decision Support Software Guidance Refresh : Clearer Rules, Broader Innovation

United States Healthcare

KM

Katten Muchin Rosenman LLP

FDA's Draft Guidance For Cosmetics Industry Explains Records-Access Authority During Inspections

United States Healthcare

WR

Wiley Rein

District Court Certifies 23(b)(3) Class Action Alleging Injury From Misrepresentations That Pet Food Was "Healthy" Despite Presence Of PFAS

United States Healthcare

MG

Manko, Gold, Katcher & Fox

Health Headlines: January 2026

United States Healthcare

GP

Goodwin Procter LLP

See more

Life Sciences, Biotechnology & Nanotechnology

Congress Probes Chinese Biotech GLP-1 Product Compliance

Although the FDA recently implemented additional safeguards related to imported GLP-1 products, the safety of GLP-1 active pharmaceutical ingredient ("API") remains a key congressional focus.

United States Healthcare

KM

Katten Muchin Rosenman LLP

NSCEB Paper Outlines Policy Options To Modernize Oversight Of Biotechnology Products

The National Security Commission on Emerging Biotechnology (NSCEB) has published a January 2026 discussion paper entitled "Creating Clear Regulatory Pathways for Biotechnology.

United States Healthcare

BC

Bergeson & Campbell

FDA's Draft Guidance For Cosmetics Industry Explains Records-Access Authority During Inspections

The U.S. Food and Drug Administration has issued a draft guidance reminding the cosmetics industry that the agency can access a variety of business records during an inspection of a product's responsible person and manufacturing/processing facility.

United States Healthcare

WR

Wiley Rein

Health Headlines: January 2026

United States Healthcare

GP

Goodwin Procter LLP

Virtual And Digital Health Digest – December 2025

United States Healthcare

AP

Arnold & Porter

New Draft Guidance Addresses FDA's Records Access Authority For Cosmetics Under MoCRA

United States Healthcare

AF

ArentFox Schiff

Virtual And Digital Health Digest

Worldwide Healthcare

AP

Arnold & Porter

Outbreak Of New World Screwworm Highlights Importance Of Insect Sterilization Technique Technology And Regulation

United States Healthcare

BD

Beveridge & Diamond

SEC Enforcement Action Targets Insider Trading In The Pharmaceutical Industry

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

See more

Healthcare

Holland & Knight Health Dose: February 3, 2026

The federal government has been in a partial shutdown since late last week, with several federal agencies – including the U.S. Department of Health and Human Services...

United States Healthcare

HK

Holland & Knight

HHS GPS V2.0 + HRSA "Strategic Priority Areas": Impact On Federal Grant Recipients Engaged In Pediatric Gender-affirming Care

Effective October 1, 2025, the US Department of Health and Human Services (HHS) implemented grants policy statement (GPS) v2.0, consistent with its prior adoption...

United States Healthcare

SR

McDermott Will & Schulte

CMS Doubles Down On RADV Audit Changes

On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024.

United States Healthcare

CM

Crowell & Moring LLP

Beyond HIPAA: Navigating The "More Stringent" Standard

United States Privacy

HH

Holland & Hart

Hospitals: Prepare Now For Mandatory Provider-Based Attestation Process

United States Healthcare

SR

McDermott Will & Schulte

Of Drugs And DTC Platforms: American Consumerism, TrumpRx, Telehealth, And The Specter Of Congressional Intervention

United States Healthcare

SM

Sheppard

The 9th Circuit's EKRA Ruling: Implications For Behavioral Health And Clinical Labs

United States Healthcare

DW

Dickinson Wright PLLC

Joint Commission Announces Key Accreditation Updates For 2026

United States Healthcare

SR

McDermott Will & Schulte

Mississippi Obstetrics System Of Care: What Hospital Leaders Need To Know

United States Healthcare

BS

Butler Snow LLP

See more

Latest Videos

See more

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

When Health Plans Become Health Leaders: Hillary Galyean Rewrites The Health Plan Playbook (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

The Journey To Better Healthcare With Ben Kruger (Video)

OK

Offit Kurman

Upcoming Events

Healthcare Regulation After Loper Bright And Corner Post: Maintaining Compliance In A Post-Chevron World

United States Healthcare

FL

Foley & Lardner

Spring Houston Healthcare Roundtable Discussion - Regulatory Change & Readiness: Leading Health Systems Through An Evolving Landscape

United States Healthcare

SM

Sheppard

Pharmaceutical Compliance Congress 2026

United States Healthcare

SM

Sheppard

AHLA Winter Institute

United States Healthcare

BB

Bass, Berry & Sims

NJ Healthcare Deals: Alignment Models And The Battle For Providers - HLA New Jersey

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

ACI: Healthcare AI Summit

United States Healthcare

M

Mintz

Inside The Life Sciences Industry Public Company Playbook: Strategies, Risks & Realities

United States Healthcare

M

Mintz

The Town Hall Table: From State Chapters To The U.S. Capitol

United States Healthcare

HK

Holland & Knight

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More